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2. Introduction 
 
2.1. Role of Na+/Ca2+ exchanger in the cardiac myocytes 
 
The Na+/Ca2+ exchange is a countertransport mechanism located in the cell membrane 
of almost every mammalian cell type. In heart muscle it was identified about forty years ago 
(Reuter and Seitz, 1968) by measuring the dependence of Ca2+ efflux from cardiac muscle on 
ionic composition. Later it was determined that it exchanges 3 Na+ for 1 Ca2+ (Reeves and 
Hale, 1984), which implies that its operation is electrogenic, i.e. results in electrical current 
flowing across the membrane (Kimura et al., 1986). The direction of this current corresponds 
to the mode of operation of the Na+/Ca2+ exchanger. In forward mode operation (Ca2+ efflux), 
an inward depolarizing current flows into the cell, while the reverse mode (Ca2+ influx) 
results in a concomitant outward current. Resulting partly from its electrogenic property, 
activity of the Na+/Ca2+ exchanger has a strong dependence on the instantaneous value of the 
membrane potential. Due to this and to the strong dependence of the Na+/Ca2+ exchanger 
activity on the electrochemical gradients of the transported ions (DiFrancesco and Noble, 
1985), operation of the Na+/Ca2+ exchanger follows a complicated time course during the 
cardiac cycle (Luo and Rudy, 1991). In addition, besides influencing the thermodynamic 
driving forces, it has been shown that intracellular Na+ and Ca2+ also regulate the Na+/Ca2+ 
exchanger in an allosteric manner (Miura and Kimura, 1989; Hilgemann et al., 1992; Weber 
et al., 2001), making the understanding of its in situ regulation and activity exceptionally 
difficult. From structural point of view, the Na+/Ca2+ exchanger protein is considered to 
consist of nine transmembrane segments that form the transporter region, and a large 
intracellular loop involved in the intrinsic regulation of the Na+/Ca2+ exchanger by Na+ and 
Ca2+ (Nicoll et al., 1999; Matsuoka et al., 1997). 
In cardiac myocytes, function of the Na+/Ca2+ exchanger belongs to the most important 
mechanisms of the Ca2+ homeostasis, and displays a major contribution to the regulation of 
the Ca2+ level during the cardiac excitation-contraction coupling. The major source of Ca2+ 
triggering the Ca2+ cycle is the L-type Ca2+ current which flows into the cell at the beginning 
of the action potential. In this phase of the action potential, the Na+/Ca2+ exchanger can 
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contribute to the Ca2+ influx (reverse mode operation) into the cell since the membrane 
potential is positive and the intracellular Ca2+ level is low. However, when the intracellular 
Ca2+ level increases at the beginning of the Ca2+ transient due to the Ca2+-induced release of 
Ca2+ from the sarcoplasmic reticulum, the Na+/Ca2+ exchanger turns into its forward mode 
operation, thereby contributing to the extrusion of Ca2+ from the cell. Relaxation of the Ca2+ 
transient is a result of the activities of tree competing mechanisms (Bers, 2001). 70-90 % of 
the cytoplasmic Ca2+ is resequestrated into the sarcoplasmic reticulum by the sarcoplasmic 
reticulum Ca2+-ATPase, 7-30 % is extruded from the cell by the Na+/Ca2+ exchanger, and 
only a small amount of Ca2+ is extruded by the slow Ca2+-transport systems, such as the 
sarcolemmal Ca2+-ATPase and the mitochondrial Ca2+-transport. The Ca2+ balance of the cell 
requires that in steady state equilibrium, the beat-to-beat Ca2+ influx and efflux must be equal 
in the wide range of physiological conditions to avoid Ca2+ loss or Ca2+ overload in the cell, 
which means that the main transmembrane Ca2+ fluxes in both directions need to be finely 
regulated. The general outline of the function of Na+/Ca2+ exchanger can show considerable 
variations depending on the experimental circumstances and the species under examination. 
For example, there is a continuous debate about the involvement of the reverse mode 
Na+/Ca2+ exchanger in the initiation of Ca2+ induced Ca2+ release and thus the systolic Ca2+ 
transient and cell contraction (Weisser-Thomas et al., 2003). Similarly, although the crucial 
role of the forward mode Na+/Ca2+ exchanger in extrusion of Ca2+ from the cell is generally 
accepted, its relative contribution to the total extruded Ca2+ can show significant variations 
depending on species and physiological/ pathological situations (Bassani et al., 1994; Bers, 
2000). Furthermore, there are emerging hypotheses regarding some unexplored roles of the 
Na+/Ca2+ exchanger, such as its suggested function in buffering the cytoplasmic Ca2+ 
movements (Hilgemann, 2004). Due to its crucial importance in the Ca2+ handling and the 
unresolved questions regarding its regulation, the role of Na+/Ca2+ exchanger in the cardiac 
cycle under physiological and pathological conditions has been extensively studied in the 
recent years (Reuter et al., 2005; Dipolo and Beauge, 2006).  
 
2.2. Pharmacology of the cardiac Na+/Ca2+ exchanger 
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An important way to examine the role of a transport system in physiological or 
pathological situations is to block the transporter with a selective inhibitor. Until recently, 
however, this possibility was hampered in case of Na+/Ca2+ exchanger because of the lack of 
potent and highly specific inhibitors. Therefore, although there are several pharmacological 
agents inhibiting the Na+/Ca2+ exchanger, the interpretation of results obtained using these 
compounds is complicated by the concomittant effects on other transport systems or ionic 
channels. For example, amiloride analogs have been used to study Ca2+ homeostasis in 
cardiac preparations (Brown et al., 1991), but these agents have also been shown to block the 
voltage gated Ca2+ channels, making the interpretation of their effects regarding the role of 
Na+/Ca2+ exchanger in Ca2+ handling rather difficult. Other pharmacological agents such as 
bepridil and amiodarone (used as antiarrhythmics) or tetracaine (used as local anesthetic) are 
also able to inhibit the Na+/Ca2+ exchanger, but again, these molecules are nonselective and 
the concentrations at which they inhibit the Na+/Ca2+ exchanger are often even higher than 
the concentrations at which they exert their primary actions (Watanabe et al., 2006). The 
exchanger inhibitory peptid (XIP), which resembles a calmodulin binding domain, has also 
been used to block the Na+/Ca2+ exchanger current, but its application is limited in 
physiological experiments because the peptide must be applied intracellularly and it also 
inhibits other Ca2+ transport systems (Enyedi and Penniston, 1993). Several trivalent and 
divalent cations are also capable to inhibit the Na+/Ca2+ exchanger, among which Ni2+ has 
been used extensively to identify the Na+/Ca2+ exchanger current in electrophysiological 
experiments. The main advantage of using Ni2+ is that it blocks Na+/Ca2+ exchanger totally in 
a reversible manner (Hinde et al., 1999). In general, these nonselective molecules and ions 
can only be used in subcellular systems or in experiments in which the Na+/Ca2+ exchanger is 
isolated by means of applying other blockers and ionic substitutions.  
Therefore, the recently developed potent and selective Na+/Ca2+ exchanger inhibitors 
present a great advance in the field of the Na+/Ca2+ exchanger research, as by using these 
molecules the role of the Na+/Ca2+ exchanger can be investigated in intact cells or tissues 
under physiological circumstances (Watanabe et al., 2006; Bouwman et al., 2006; Iwamoto, 
2004a). The two most selective and widely used Na+/Ca2+ exchanger inhibitors (see chemical 
structures in Fig. 1) in the literature are the aniline derivative SEA0400 
(2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxy-aniline) and the the isothiourea 
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derivative KB-R7943 (2-[2-[4-94-nitrobenzyloxy)phenyl]ethyl]isothiourea) (Tanaka et al., 
2002; Matsuda et al., 2004 and Watanabe et al., 2006). When examining the role of the 
Na+/Ca2+ exchanger in physiological as well as pathological circumstances by using 
pharmacological tools, it is important to know the selectivity, potency and possible direction 
dependence of the inhibitors. Therefore, the first aim of the present work was to compare the 
pharmacological profile of the two recently introduced Na+/Ca2+ exchanger inhibitor, 
KB-R7943 and SEA0400.  
An early study investigating the pharmacological effect of KB-R7943 concluded that 
this compound affects the Na+/Ca2+ exchanger in a Ca2+ dependent manner under certain 
experimental circumstances (Watano and Kimura, 1998), suggesting that an interaction might 
exist between the drug and the intrinsic regulatory mechanisms of the Na+/Ca2+ exchanger. 
Similar interaction has been suggested to be involved in the mechanism of action of 
SEA0400, as its blocking effect was found to be dependent on the intracellular Na+ 
concentration, and related inversely to the intracellular Ca2+ concentration (Lee et al., 2004; 
Bouchard et al., 2004). However, these experiments were carried out in an expressed system 
using non-phsyological ionic concentrations to measure the Na+/Ca2+ exchanger current. 
Therefore, our second aim in this work was to investigate the possible interaction between the 
intracellular Ca2+ concentration and the inhibitory effect of SEA0400 in adult cardiac 
myocytes using physiological ionic concentrations.  
 
2.3. Therapeutic potential of the Na+/Ca2+ exchanger inhibitors 
 
In the recent years, several studies indicated that inhibition of the Na+/Ca2+ exchanger 
can be beneficial in experimental models of cardiac disorders. Most of these studies 
examined the involvement of the Na+/Ca2+ exchanger in the ischemic damage of the 
myocardium. Based on the thermodynamics of the operation of the Na+/Ca2+ exchanger 
(DiFrancesco and Noble, 1985), intracellular accumulation of Na+ in ischemic/reperfused 
myocardium favors the reverse mode operation of the Na+/Ca2+ exchanger, which may 
contribute to the intracellular accumulation of Ca2+ leading to cell damage and death 
(Imahashi et al., 1999; Murphy et al., 1999). Therefore, it can be speculated that 
pharmacological inhibition of the Na+/Ca2+ exchanger may display cardioprotective effects 
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under such circumstances. In accordance with this hypothesis, it has been reported that 
SEA0400 (Takahashi et al., 2003) and KB-R7943 (Motegi et al., 2007; Seki et al., 2002) 
reduced infarct size in rat and rabbit (Magee et al., 2003) hearts after ischemia/reperfusion. 
The beneficial effects exerted by the Na+/Ca2+ exchanger inhibitors in ischemia/reperfusion 
were also demonstrated in large animal models such as dog (Takahashi et al., 2004) and pig 
(Inserte et al., 2002). The above and other studies (Hagihara el al., 2005; Namekata et al., 
2005 and 2006; Feng et al., 2006) also examined the proposed mechanisms of the observed 
protective effects of the the Na+/Ca2+ exchanger inhibitors in such circumstances. Indeed, it 
has been verified that the most likely mechanism of action was the prevention of the 
excessive Ca2+ overload by inhibiting the reverse mode operation of Na+/Ca2+ exchanger. The 
possible therapeutic potential of Na+/Ca2+ exchanger inhibitors in ischemia-reperfusion injury 
was recently reviewed by Lee et al. (Lee et al., 2005). 
Forward mode operation of Na+/Ca2+ exchanger may also be related to pathological 
events, like early and delayed afterdepolarizations, in the heart when the intracellular Ca2+ is 
elevated. In forward mode (Ca2+ efflux) operation, an inward depolarizing current flows into 
the cell, which, when the intracellular Ca2+ level is elevated, can be strong enough to induce 
afterdepolarizations leading to severe cardiac arrhythmias. Supporting this idea, a suppressive 
effect of SEA0400 on digitalis-induced arrhythmias was observed in canine models 
(Nagasawa et al., 2005). We also found that SEA0400 effectively decreased the occurrence of 
early and delayed afterdepolarizations in canine cardiac tissues (Nagy et al., 2004). The role 
of Na+/Ca2+ exchanger in such circumstances and the possible antiarrhythmic potential of its 
inhibitors were reviewed by Sipido et al. (Sipido et al., 2006).  
Most of the above studies investigated end point parameters related to pathological 
consequences of myocardial Ca2+ overload, like contractile dysfunction, infarct size, or 
incidence of arrhythmias. However, although it is closely related to the potential therapeutic 
uses of the Na+/Ca2+ exchanger inhibitors, relatively few works investigated directly the 
effects of the reduced Na+/Ca2+ exchanger function on the Ca2+ homeostasis itself. 
KB-R7943, XIP or non-pharmacological tools were used in these studies (Satoh et al., 2000; 
Hobai et al., 2004; Tadros et al., 2002), but to the our best knowledge, there was no such 
study using SEA0400. Therefore, the next aim in this work was to directly study how partial 
inhibition of Na+/Ca2+ exchanger by the selective pharmacological agent SEA0400 influences 
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the elements of Ca2+ handling in cardiac cells from rat and dog. Finally, the positive inotropic 
effect observed in rat cardiac myocytes was investigated further regarding the possible 
autoregulative changes in the Ca2+ homeostasis that can be expected to occur after any 
disturbance in the steady state balance of the cellular Ca2+ fluxes (Eisner, 2000).  
 
3. Major experimental goals 
 
1. Comparison of the Na+/Ca2+ exchanger blocking potency and its possible direction 
dependence of SEA0400 and KB-R7943 in whole cell patch clamp experiments. 
 
2. Investigation of the possible relationship between the intracellular Ca2+ concentration and 
the inhibitory action of the SEA0400 in whole cell patch clamp experiments. 
 
3. Effect of Na+/Ca2+ exchanger inhibition by SEA0400 on Ca2+ transients in intact field 
stimulated rat and dog cardiac myocytes. 
 
4. Further analysis of the effect of the Na+/Ca2+ exchanger inhibition by SEA0400 on Ca2+ 
cycling in rat cardiac myocytes by applying the perforated patch clamp technique. 
 
4. Materials and methods 
 
4.1. Animal care 
 
The studies were conducted in accordance with the standards of the European 
Community guidelines on the care and use of laboratory animals and the protocols had been 
approved by the Ethical Committee for Protection of Animals in Research of the University 
of Szeged, Szeged, Hungary. 
 
4.2. Isolation of dog cardiac myocytes 
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Single canine ventricular cells were obtained from hearts of adult mongrel dogs using 
the segment perfusion technique. The animals (10–20 kg) were anaesthetised with i.v. 
injection of 30 mg/kg thiopental. After opening the chest the heart was rapidly removed and a 
segment of left ventricular wall was perfused through the anterior descending coronary artery 
using a gravity flow Langendorff apparatus. The perfusion solution was the modified MEM 
solution (Minimum Essential Medium Eagle, Joklik modification; Sigma, M-0518), 
supplemented with Ca2+ (1.2 mM), HEPES (10 mM), taurine (2.5 g/l), pyruvic acid (175 
mg/l), ribose (750 mg/l) and titrated to pH 7.2 with 1 M NaOH. After washing out the blood, 
the ventricular segment was perfused with nominally Ca2+-free solution for 10 min. The 
digestion was achieved by recirculation (approx. 12 ml/min) of the perfusion medium 
supplemented with Ca2+ (75 µM) and collagenase (0.5 mg/ml, Sigma type I) for 40 min. 
During the isolation procedure the solutions were gassed with oxygen and the temperature 
was maintained at 35°C. Finally the left ventricular wall segment was minced and gently 
agitated. The cells freshly released from the tissue were stored at room temperature before 
use. At least 60% of the cells were rod shaped and showed clear striation when the external 
Ca2+ was restored. 
 
4.3. Isolation of rat cardiac myocytes 
 
Hearts from Sprague-Dawley rats, weighing 200-250 g, were retrogradely perfused at 
37 °C for 5 min with Krebs-Henseleit solution (containing in mM: NaCl 118.5, KCl 4, CaCl2 
2, MgSO4 1.0, NaH2PO4 1.2, NaHCO3 25, and glucose 11.1). The pH of this solution was 7.4 
when saturated with a mixture of 95 % O2 and 5 % CO2. Perfusion was continued with 
Ca2+-free Krebs-Henseleit solution for further 5 min, then the perfusate was completed with 
collagenase (0.05 %, type I), hyaluronidase (0.05 %) and CaCl2 (200 µM) and the heart was 
perfused for additional 10 min. Finally the left ventricular myocardium was minced and 
gently agitated. The cells freshly released from the tissue were stored at room temperature 
before use. The storage solution contained in mM: KOH 89, glutamate 70, taurin 15, KCl 30, 
KH2PO4 10, HEPES 10, MgCl2 0.5, glucose 11, EGTA 0.5, and pH was set to 7.3 with KOH. 
The cells were rod shaped and showed clear striation when the external calcium was restored. 
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4.4. Measurement of the Na+/Ca2+ exchanger current (INa/Ca) in isolated dog ventricular 
cells and estimation of the blocking potency of SEA0400 and KB-R7943 
 
Na+/Ca2+ exchanger current (INa/Ca) was recorded in whole cell patch clamp 
experiments as a Ni2+ sensitive current. This method is based on the observation that Ni2+ 
blocks the INa/Ca completely (Hinde et al., 1999). However, as Ni2+ also blocks several other 
membrane currents, these experiments have to be carried out with the other currents (Na+, K+, 
Ca2+ and Na+/K+ pump currents) already blocked by specific inhibitors (Beuckelmann and 
Wier, 1989). Thus after establishing the whole-cell configuration in normal Tyrode solution 
(containing in mM: NaCl 144, NaH2PO4 0.33, KCl 4.0, CaCl2 1.5, MgCl2 0.53, glucose 5.5 
and HEPES 5.0, pH = 7.4), the cell was superfused with a special K+-free bath solution 
(containing in mM: NaCl 135, CsCl 10, CaCl2 1, MgCl2 1, BaCl2 0.2, NaH2PO4 0.33, TEACl 
10, HEPES 10, glucose 10, pH=7.4) supplemented with 20 µM ouabain, 1 µM nisoldipine 
and 50 µM lidocaine in order to block Na+, K+, Ca2+ and Na+/K+ pump currents. 
Micropipettes were fabricated from borosilicate glass capillaries having resistance of 
2-3 MΩ when filled with the pipette solution contained (in mM) CsOH 140, aspartic acid 75, 
TEACl 20, Mg-ATP 5, HEPES 10, NaCl 20, EGTA 20, CaCl2 10 (pH=7.2). INa/Ca was 
recorded using ramp pulses (having a velocity of 100 mV/s) delivered at a rate of 0.05 Hz. 
The membrane was initially depolarised from the holding potential of –40 mV to +60 mV, 
then hyperpolarised to –100 mV, and finally the membrane potential returned to the holding 
potential. Outward and inward INa/Ca were determined during the descending limb of the ramp 
at +40 and –80 mV, respectively, as indicated by the arrows in Fig. 2A,B. After taking the 
control record in K+-free solution, the cell was superfused with the given concentration of 
SEA0400 or KB-R7943, and finally 10 mM NiCl2 was added in order to fully block INa/Ca. 
Thus, total INa/Ca was determined at both membrane potentials as a Ni2+-sensitive current by 
subtracting the third record from the first one. The fraction of block induced by SEA0400 or 
KB-R7943 was expressed as percent of total INa/Ca.  
 
4.5. Dependence of the inhibitory action of SEA0400 on the intracellular Ca2+ 
concentration 
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Ca2+ dependence of the exchanger inhibiting effect of SEA0400 was investigated in 
dog myocytes using the protocol described above, except that the free Ca2+ concentration of 
the pipette solution was buffered to different levels by adding 5 or 15 mM Ca2+ to 20 mM 
EGTA, and 5.3 or 14 mM Ca2+ to 20 mM BAPTA. Calculated free Ca2+ concentrations were 
55 and 500 nM with EGTA, and 140 and 1000 nM in case of BAPTA, respectively. The free 
Ca2+ concentrations were calculated using WinMaxC software (Patton et al., 2004; http: 
//www. stanford.edu /~cpatton/winmaxc2.html), and it was verified that the free Ca2+ level in 
all cases remained in the actual buffered range. 
 
4.6. Measurement of intracellular Ca2+ concentration and cell shortening in field 
stimulated rat and dog ventricular cells 
 
Changes in intracellular free Ca2+ concentration were assessed by the ratiometric 
fluorescence technique using Fura-2-AM. Cells were incubated with 2 µM Fura-2-AM in the 
storage solution for 30 min followed by at least 1 hour of deestherification. After the 
incubation period cells were superfused in the experimental chamber with normal Tyrode 
solution (see above) at 35 ºC and stimulated using an electronic stimulator (DS-R1, 
Fonixcomp Ltd, Hungary) at 1 or 4 Hz via a pair of platinum electrodes. The chamber was 
attached to the stage of an inverted fluorescent microscope (IX71, Olympus, Japan). Cells 
were excited at 360 and 380 nm from a xenon arc lamp (Optosource, Cairn, UK). The 
excitatory wavelengths were selected using a galvanometric monochromator (Optoscan, 
Cairn, UK) operating at 100 Hz. The emitted light was band pass filtered and directed to a 
photomultiplier tube. The demultiplexed optical signals (360/380) were recorded using the 
Acquisition Engine software (Cairn, UK). Changes in intracellular free Ca2+ levels were 
approximated by the ratio of the fluorescence intensity obtained at 360 and 380 nm excitation 
after correction for nonspecific background fluorescence. Cell shortening was recorded using 
a video edge detector system (VED-105, Crescent Electronics, Sandy, Utah, USA). 
Concentrations of SEA0400 applied in the superfusion solution were 0.3 µM in the 
experiments on rat myocytes, and 0.1, 0.3 and 1 µM in case of dog myocytes, and 5 min was 
allowed for development of full drug effect.  
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In separate experiments, activity of the Na+/Ca2+ exchanger was modulated in dog 
myocytes by decreasing the extracellular Na+ concentration from 144 to 70 mM (replaced 
with choline-chloride), and changes in the Ca2+ transients were recorded as described above. 
 
4.7. Recording the caffeine induced Ca2+ transients in patch clamped dog cardiac 
myocytes  
 
Cells loaded with Fura-2-AM were superfused in the experimental chamber with 
normal Tyrode solution at room temperature. Composition of the pipette solution in these 
experiments was (in mM) CsCl 140, TEACl 20, MgATP 5, NaCl 20, HEPES 10, pH = 7.2. 
After establishing the whole cell configuration, conditioning depolarization pulses (200 ms in 
duration, from -80 to 0 mV) were applied to the cell at a frequency of 0.5 Hz in order to 
standardize the sarcoplasmic reticulum Ca2+ content. Then the holding potential was set to 
-80 mV to prevent any disturbances resulting from the changes of the membrane potential 
and with a standardized delay, total release of the sarcoplasmic reticulum Ca2+ content was 
induced by rapid application of 10 mM caffeine via a side arm of the cell chamber. The 
caffeine induced Ca2+ transients and total membrane current were recorded in the absence and 
presence of 10 mM Ni2+ in order to investigate the relative involvement of the Na+/Ca2+ 
exchanger in the relaxation of the Ca2+ transients. 
 
4.8. Recording the L-type Ca2+ current, intracellular Ca2+ transient, and cell shortening 
in patch clamped rat cardiac myocytes 
 
Perforated cell membrane configuration of the patch clamp technique was used to 
record the L-type Ca2+ current in parallel with the recording of intracellular Ca2+ transient. 
The main advantage of this method over the whole cell patch clamp configuration for 
measuring the L-type Ca2+ current is that the run down phenomenon of the L-type Ca2+ 
current can be avoided because with perforated patch clamp a good electrical access can be 
achieved without dialyzing the intracellular content of the cell. Further advantage of this 
method when studying the Ca2+ cycling is that the other determinants of the intracellular Ca2+ 
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transient (Ca2+ release channel and the sarcolasmic reticulum Ca2+ pump) remain intact as 
well. 
Cells loaded with Fura-2-AM were superfused at 35 °C with normal Tyrode solution 
(see above) containing 5 mM of 4-aminopyridine and 0.15 µM of BaCl2 to suppress K+ 
currents. Micropipettes were fabricated from borosilicate glass capillaries having resistance 
of 2-3 MΩ when filled with pipette solution (containing in mM: CsCl 140, TEACl 20, 
MgATP 5, NaCl 20, HEPES 10, EGTA 10, pH = 7.2). This pipette solution was 
supplemented with 220 µg/ml amphotericin B in order to develop a reasonably good 
electrical access to cell interior. As amphotericin B penetrated the membrane patch, the series 
resistance decreased gradually below 15 MΩ, which was compensated for (usually at 80%). 
L-type Ca2+ currents and the intracellular Ca2+ transients were evoked by a composite voltage 
command. First a prepulse to -40 mV was applied from the holding potential of -80 mV for 
40 ms, then the membrane potential was immediately clamped to 0 mV, which was followed 
by a voltage ramp of 50 ms duration back to the holding potential (from 0 mV to -80 mV). 
This voltage command was applied in trains, each containing 100 impulses, delivered at a 
frequency of 4 Hz. These trains were applied twice, just before each measurement (i.e. once 
before, and once after the 5 min period of incubation with the vehicle or 0.3 µM SEA0400). 
Steady-state conditions could be achieved by the end of these trains (after 25 s). Between the 
trains the membrane was continuously kept at the holding potential of -80 mV in order to 
minimize the deterioration of the perforated cell membrane. Effect of SEA0400 on 
voltage-current characteristic of the L-type Ca2+ current was measured in whole cell patch 
clamp configuration by applying square pulse voltage commands for 100 ms from the 
holding potential of -40 to +60 mV in steps of 5 mV at a frequency of 0.2 Hz. Measurements 
were performed using Axopatch 1D amplifier controlled by pClamp 6 software (Axon 
Instrument). Intracellular Ca2+ transients and cell shortening were recorded as described 
above. 
 
4.9. Drugs 
 
All chemicals, except SEA0400, KB-R7943 and Fura-2 AM were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). SEA0400 was synthesized (Aibe et al,. 2000) at the 
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Department of Pharmacological Chemistry (University of Szeged, Szeged, Hungary), Fura-2 
AM was from Molecular Probes Inc. (Eugene, Oregon, USA). SEA0400 was dissolved in 
dimethyl sulfoxide (vehicle) and its final concentrations were 0.1, 0.3 or 1 µM when diluted 
in Tyrode solution. 
 
4.10. Data handling and statistics 
 
Data of the percent inhibition of the total INa/Ca at different concentrations of SEA0400 
and KB-R7943 were fitted to the Hill equation. Original traces of Ca2+ transients, cell 
shortening, and Ca2+ current are shown as average of 10 consecutive recordings (obtained 
during the last 10 members of the train in the perforated patch clamp experimets). Changes in 
the control (from baseline to vehicle) and SEA0400 (from baseline to SEA0400) groups were 
expressed as mean percent changes ± S.E.M. in case of experiments on rat. Changes after 
administration of SEA0400 observed in experiments on dog mocytes were normalized to the 
corresponding pre-drug values and were expressed as mean ± S.E.M. Means were compared 
statistically between groups using Student's t test for dependent or independent groups as 
appropriate. Data on the Ca2+-dependent blocking effect of SEA0400 were analysed using 
ANOVA followed by linear trend test. Statistical calculations were carried out using 
Statistica 6.0 (StatSoft Inc.). Differences were considered significant when P was <0.05.  
 
5. Results 
 
5.1. Comparison of the estimated EC50 values of SEA0400 and KB-R7943 
 
INa/Ca was recorded as a Ni2+-sensitive current using the descending limb of a ramp 
pulse changing slowly from +60 to –100 mV during 1.6 s. Outward and inward INa/Ca were 
determined at +40 and –80 mV, respectively (Fig. 2A,B; for further details see Materials and 
methods). SEA0400 and KB-R7943 suppressed both inward and outward INa/Ca, i.e. the 
Ni2+-sensitive current was significantly decreased by these compounds in a 
concentration-dependent manner (Fig. 2C,D). Data were fitted to the Hill equation and the 
results are presented in Table 1. The most striking difference between the effects of SEA0400 
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and KB-R7943 was the difference in their affinity: the EC50 value (defined by the inflexion 
point of the Hill plot) was lower for SEA0400 than KB-R7943 by approximately 1.5 orders 
of magnitude when blocking either inward or outward currents. Since full inhibition of INa/Ca 
was not achieved under our experimental conditions, drug concentrations causing 50% 
reduction of the currents (indicated by the dashed lines in Fig. 2C,D) were higher than the 
respective EC50 values. These numbers are presented in the last column of Table 1. No 
significant difference was seen in the SEA0400-induced suppression of inward and outward 
INa/Ca. In contrast, KB-R7943 suppressed outward INa/Ca more effectively than inward INa/Ca at 
concentrations higher than 3 µM. The maximal blockade of inward INa/Ca produced by the 
highest concentration of KB-R7943 (50 µM) was only 44.6±9.1%. The second difference 
seen between the effects of the two drugs was in their Hill coefficients: a value of close to 
unity was obtained for SEA0400, whereas it was around 2 in the case of KB-R7943.  
 
5.2. Ca2+ dependence of the Na+/Ca2+ exchanger blockade by SEA0400 in patch clamped 
dog cardiac myocytes 
 
Outward as well as inward INa/Ca were recorded in dog cardiac myocytes as described 
above. Experimental groups were constructed according to the concentrations of the free Ca2+ 
used in the patch pipettes. Calculated free Ca2+ concentrations in the pipette solutions were 
55, 140, 500 and 1000 nM. The percent values of the INa/Ca inhibition by SEA0400 applied at 
a concentration of 1 µM are shown in Fig. 3. With the increasing concentrations of the free 
Ca2+ in the pipette solution, SEA0400 exhibited a significant decreasing tendency in its 
blocking effect on both outward and inward INa/Ca, resulting in significant differences 
between the groups of lower and higher Ca2+ levels (outward current: 58.4 ± 8.3 % in 55 nM 
Ca2+ group versus 39.1 ± 6.7 % in the 500 nM Ca2+ group, P< 0.05; inward current 78.2 ± 9.3 
% in 55 nM Ca2+ group versus 42.7 ± 4.7 % in the 500 nM Ca2+ group, P< 0.05). Regarding 
the outward current, the percent inhibition showed a monoton decrease, but the blocking 
values observed in the 500 and 1000 nM Ca2+ level groups did not differ from each other 
neither in case of the outward nor in the inward current. This may suggest that the critical 
Ca2+ level in the inverse Ca2+-dependent Na+/Ca2+ exchange blocking phenomenon may be in 
the lower range of the physiological Ca2+ levels. On the other hand, it must be kept in mind 
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that, although the total concentrations of Ca2+ and the Ca2+ chelators needed to achieve a 
buffered free Ca2+ level were calculated carefully, the actual momentary Ca2+ level near the 
cell membrane cannot be predicted precisely, because the cytoplasmic surface of the cell 
membrane also has a significant Ca2+ buffering capacity, which may interact with the Ca2+ 
level at the vicinity of the Na+/Ca2+ exchanger. Therefore, the most important finding in these 
experiments was the tendency itself, and only careful conclusions can be made regarding the 
role of the absolute values of the free Ca2+ concentrations.  
 
5.3. Effect of SEA0400 on the intracellular Ca2+ transient and cell shortening in field 
stimulated rat cardiac myocytes 
 
Rat cardiac myocytes were stimulated at a constant frequency of 4 Hz through a pair of 
platinum electrodes. After establishing steady state contractions and Ca2+ transients, the 
perfusion was switched to the solution containing 0.3 µM of SEA0400 and a period of 5 min 
was allowed to develop full drug effect. Original recordings of the intracellular Ca2+ 
transients and cell shortening before and after administration of 0.3 µM SEA0400 or vehicle 
are presented in Fig. 4. Vehicle alone failed to affect the intracellular Ca2+ transient and cell 
shortening (Fig. 4A,C). In contrast, administration of SEA0400 at a concentration of 0.3 µM 
resulted in an increased amplitude of both intracellular Ca2+ transient and cell shortening 
(Fig. 4B, D). In some experiments a moderate elevation in diastolic Ca2+ and baseline cell 
length was observed after SEA0400. Effects of SEA0400 on these parameters are 
summarized as percent changes in Fig. 5A-D. The SEA0400-induced increase in the 
amplitude of Ca2+ transient (31.6 ± 8.8 % in SEA0400, n = 6 versus 8.5 ± 3.8 % in vehicle, n 
= 7, P < 0.05) and in cell shortening (45.5 ± 14.9 % in SEA0400 versus 2.0 ± 15.2 % in 
vehicle, P< 0.05) were statistically significant, while elevation of the diastolic Ca2+ and 
baseline cell length was moderate and not significant statistically (6.1± 3.3 % in SEA0400 
versus 0.9 ± 1.4 % in vehicle, P = 0.13, for diastolic Ca2+; and 5.5 ± 2.9 % in SEA0400 
versus 3.0 ± 0.8 % in vehicle, P = 0.22, for baseline cell length). 
Since the relaxation kinetics of the Ca2+ transient may reflect kinetic properties of Ca2+ 
handling, the decay time constant of the Ca2+ transients was determined using 
monoexponential fit. No significant changes were observed in this parameter in the presence 
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of either SEA0400 (67.4±5.9 ms before and 72.0±2.4 ms after, n=6) or vehicle (78.1±5.7 ms 
before and 78.5±4.3 ms after, n=7). 
 
5.4. Effect of SEA0400 on the intracellular Ca2+ transient and cell shortening in field 
stimulated dog cardiac myocytes, and contribution of the Na+/Ca2+ exchanger to the 
extrusion of Ca2+ from the cell   
 
Dog cardiac myocytes were stimulated at a constant frequency of 1 Hz through a pair of 
platinum electrodes. After establishing steady state contractions and Ca2+ transients, the 
perfusion was switched to the solution containing 0.1, 0.3 or 1 µM of SEA0400. Original 
recordings of the intracellular Ca2+ transients and cell shortening before and after 
administration of SEA0400 are presented in Fig. 6. Irrespective to the applied concnetrations, 
SEA0400 failed to affect significantly the intracellular Ca2+ transient and cell shortening (Fig. 
6A,B). The results are summarized as changes normalized to the corresponding pre-drug 
values and shown in Fig. 7A,B. SEA0400 did not exert any consequent effect with the 
increasing concentrations, and there were no any group with statistically significant change. 
To investigate why partial inhibition of the Na+/Ca2+ exchanger produced no apparent 
effect on the Ca2+ handling in dog myoctes, we estimated the relative contributions of the 
different Ca2+ removal systems to the extrusion of Ca2+ from the cell. In patch clamped dog 
cardiac myocytes release of Ca2+ from sarcoplasmic reticulum was induced by rapid 
application of 10 mM caffeine after a conditioning train of depolarizations. As caffeine also 
prevents the accumulation of Ca2+ into the sarcoplasmic reticulum, the relative contribution of 
the remaining Ca2+ extrusion systems can be estimated in this experimental setting. 
Normalized traces of the intracellular Ca2+ and the parallel current recordings are shown in 
Fig. 8. In control conditions (Fig. 8. open symbols), the observed relaxation kinetics of the 
caffeine induced Ca2+ transient could be attributed to the combined action of the forward 
mode Na+/Ca2+ exchanger, which generated an inward current, and other systems such as the 
sarcolemmal Ca2+ pump, and half relaxation time was 1730 ms. However, after blocking the 
Na+/Ca2+ exchanger totally by 10 mM Ni2+, which was evident by the disappearence of the 
inward exchanger current (Fig. 8. closed symbols), the relaxation slowed substantially, 
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requiring 8260 ms for half relaxation. Therefore, inactivation of the Na+/Ca2+ exchanger 
resulted in an 4.8 -fold increase in the relaxation rate. 
 We investigated further the effects of Na+/Ca2+ exchanger function on the intracellular 
Ca2+ transient in dog cardiac myocytes, by utilizing the strong dependence of the exchanger 
on the electrochemical gradient of Na+. We recorded the intracellular Ca2+ transient in field 
stimulated dog myocytes before and after changing the concentration of extracellular Na+ 
from 144 to 70 mM. As shown in Fig. 9., the decrease of the extracellular Na+ resulted in a 
significant elevation of the amplitude of the systolic Ca2+ transient. 
 
5.5. Effect of SEA0400 on the intracellular Ca2+ transient, cell shortening, and L-type 
Ca2+ current in patch clamped rat cardiac myocytes 
 
In these experiments we aimed to reproduce the effects of SEA0400 on the intracellular 
Ca2+ transient and contractility obtained in the field stimulated rat cells, and to record L-type 
Ca2+ current simultaneously under perforated patch clamp conditions. Myocytes were paced 
through the patch pipette by applying trains of composite voltage commands at 4 Hz, as 
previously described in the methods section. Fig. 10A-C show original recordings of 
intracellular Ca2+ transients, cell shortening, and L-type Ca2+ current measured 
simultaneously in the voltage clamped cells. Recordings were made under control conditions 
and after application of 0.3 µM SEA0400 or vehicle. Similar to results obtained in the field 
stimulated cells, SEA0400 increased the amplitude of Ca2+ transients (32.2 ± 4.7 % in 
SEA0400, n = 5 versus -11.2 ± 6.9 % in vehicle, n = 4; P < 0.05) and enhanced cell 
shortening (25.9 ± 5.4 % in SEA0400 versus 0.9 ± 6.8 % in vehicle, P < 0.05) under voltage 
clamp conditions as well. In addition, both the amplitude of the L-type Ca2+ current 
(-24.9 ± 5.0 % in SEA0400, n = 5, versus -6.5 ± 6.7 % in vehicle, n = 4, P < 0.05) and the 
time required to half inactivation of the current (-7.9 ± 1.7 % in SEA0400, n = 5, versus 
-2.0 ± 1.5 % in vehicle, n = 4, P < 0.05) were significantly decreased by SEA0400. Effects of 
SEA0400 on the parameters above are summarized as percent changes in Fig. 11A-D 
indicating that the effect of SEA0400 was statistically significant in the case of each 
monitored parameter when compared to effects of the vehicle.  
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A crucial point in these experiments was the decrease in the L-type Ca2+ current, which 
was a hypothetical consequence of the elevated Ca2+ transients. In order to verify that 
SEA0400 itself did not inhibit the L-type Ca2+ current at the applied concentration of 0.3 µM, 
we recorded the L-type Ca2+ current in whole cell patch clamp configuration. In this 
experimental setting, 10 mM EGTA applied in the pipette solution effectively buffered the 
intracellular Ca2+ transient. An original recording of the L-type Ca2+ current and the 
voltage-current characteristic are presented in Fig. 12. Application of SEA0400 affected 
neither the amplitude nor the voltage-current characteristic of the L-type Ca2+ current. 
 
6. Discussion 
 
6.1. Inhibition of the Na+/Ca2+ exchanger by SEA0400 and KB-R7943 and its relation to 
their pharmacological effects 
 
We have compared the blocking effects of SEA0400 and KB-R7943 on the Na+/Ca2+ 
exchanger current in canine ventricular myocytes, a preparation which most resembles human 
cardiac cells in electrophysiological properties. Regarding the blockade of the Na+/Ca2+ 
exchanger current, three major differences were observed. First, the EC50 values were higher 
by 1.5 orders of magnitude for KB-R7943 than for SEA0400. Secondly, KB-R7943 at 
concentrations higher than 3 µM blocked outward INa/Ca more strongly than inward INa/Ca, in 
contrast with SEA0400. Finally, the Hill coefficient obtained for SEA0400 was close to 1, 
whereas it was around 2 in the case of KB-R7943. These differences suggest that the 
Na+/Ca2+ exchanger blockade induced by the two agents may involve different mechanisms. 
Comparing the EC50 values of these inhibitors for the Na+/Ca2+ exchanger current and the 
L-type Ca2+ current (Birinyi et al., 2005), it can be concluded that low concentrations of 
SEA0400 display good selectivity for Na+/Ca2+ exchanger over L-type Ca2+ current in canine 
ventricular cells, having EC50 values for these transporters 0.11 and 3.6 µM respectively. 
These results suggest that submicromolar concentrations of SEA0400 may be effectively 
applied to study the role of Na+/Ca2+ exchanger in Ca2+ handling. In contrast to SEA0400, 
KB-R7943 had a similar potency to block the Na+/Ca2+ exchanger current and the L-type 
Ca2+ current (3.3 and 3.2 µM, respectively). Due to this, and due to the higher efficacy to 
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block the outward than the inward exchanger current, KB-R7943 can be considered as a 
peculiar Ca2+ entry blocker having a dual mechanism to reduce Ca2+ influx.  
Comparing our results obtained in canine ventricular cells with those of Tanaka et al. 
(Tanaka et al., 2002) obtained in guinea-pig myocytes, significant differences are seen. 
Tanaka et al. observed complete block of the Na+/Ca2+ exchanger current at higher 
concentrations of SEA0400 and KB-R7943, and no difference was observed between the 
inward and outward current block induced by KB-R7943. Although the exact EC50 values 
were not reported in that study, the half-maximal block of the exchanger current was 
achieved at lower drug concentrations (with both SEA0400 and KB-R7943) in guinea-pig 
than canine ventricular cells. It is not clear at present whether differences in the effects of 
SEA0400 and KB-R7943 in guinea pig and dog represent true interspecies differences 
between the two preparations or are due to differences in the experimental conditions. 
Mammalian ventricular preparations are known to express only one single isoform of the 
Na+/Ca2+ exchanger (NCX1); thus, the differences cannot be explained by contributions of 
different Na+/Ca2+ exchanger isoforms in the two species. It is worthy of mention, however, 
that NCX1 is characterised by a cluster of six exons coding for a variable region in the 
C-terminus of the polypeptide, and alternative splicing of these exons may generate multiple 
tissue-specific variants of NCX1 (Quednau et al. 1997). Differences in splicing might cause 
differences in drug sensitivity, as single mutations were shown to modify the effect of 
KB-R7943 on Na+/Ca2+ exchanger (Iwamoto et al. 2001; Shigekawa et al. 2002). 
In some recent studies both SEA0400 and KB-R7943 were reported to prevent or 
reduce ischaemia/reperfusion-induced cellular injuries and arrhythmias in various 
mammalian cardiac preparations (Yamamura et al. 2001; Takahashi et al. 2003); however, 
the opposite was found by Miyamoto et al. (2002) in dog. Furthermore, KB-R7943 was also 
effective against ouabain-induced arrhythmias in guinea-pig (Watano et al. 1999), while 
SEA0400 (1 µM) suppressed early afterdepolarisations in papillary muscles and delayed 
afterdepolarisations in Purkinje fibre preparations of the dog (Nagy et al. 2004). The 
underlying mechanisms are believed to involve the reduction of Ca2+ entry via the reverse 
mode operation of the exchanger during reperfusion (Watano et al. 1999) and inhibition of 
the forward mode operation, that generates an inward current thought to induce 
afterdepolarisations under pathological conditions (Nagy et al. 2004). In the first case, a 
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reverse over forward mode selectivity of the Na+/Ca2+ exchanger blockade was postulated 
with KB-R7943 (Watano et al. 1996). This was exactly the case in the present study with 
higher concentrations of KB-R7943; however, other investigators (Kimura et al. 1999; Lu et 
al. 2002) failed to demonstrate this direction-dependent selectivity. Therefore, based on the 
similar EC50 values, it is possible that prevention of Ca2+ overload by 5 µM KB-R7943 in 
strophantidin-treated rat myocytes (Satoh et al. 2000) is due not only to its blocking effect on 
the reverse Na+/Ca2+ exchanger, but also to the inhibition of the L-type Ca2+ current. 
Similarly, the negative inotropic action of 3 µM KB-R7943 in isolated canine heart 
(Kurogouchi et al. 2000) might be best explained by the concomitant suppression of L-type 
Ca2+ current. Combined suppression of the Na+/Ca2+ exchanger and the L-type Ca2+ current is 
not a unique feature of KB-R7943, but has been observed with several antiarrhythmic agents, 
such as amiodarone (Watanabe and Kimura, 2000), bepridil (Watanabe and Kimura, 2001) or 
aprindine (Watanabe et al., 2002), and its contribution to the antiarrhythmic potency of these 
compounds has to be considered. Whatever the mechanism of the prevention of the 
intracellular Ca2+ overload, the concomitant suppression of the Na+/Ca2+ exchanger and the 
L-type Ca2+ current may be therapeutically beneficial, since due to the parallel reduction of 
transsarcolemmal Ca2+ influx and efflux, Ca2+ balance can be achieved at a lower cost of 
metabolic energy. In contrast, a more selective compound devoid of any effect on the L-type 
Ca2+ current at least at lower concentrations, such as SEA0400, must be used for studying the 
role of the Na+/Ca2+ exchanger itself in physiological as well as pathological conditions. 
 
6.2. Inverse Ca2+-dependent inhibition of the Na+/Ca2+ exchanger by SEA0400 
 
It has been suggsted that SEA0400 exerts its inhibitory action by modifying the 
intrinsic regulatory machinery of the Na+/Ca2+ exchanger. Using site directed mutagenesis, 
Iwamoto et al. (Iwamoto et al., 2004) pointed out that several amino acid residues in the 
region of the cytoplasmic loop of the Na+/Ca2+ exchanger are critical for the inhibitory effect 
of SEA0400. On the other hand, it is well known that the cytoplasmic loop of the exchanger, 
possessing the exchanger inhibitory peptide (XIP) region and the regulatory Ca2+ binding 
sites, is primarily involved in various regulatory properties of the Na+/Ca2+ exchanger 
(Matsuoka et al., 1993). Thus, if the cytoplasmic loop of the exchanger plays a central role in 
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both mediating the inhibitory effect of SEA0400 and in intrinsic regulatory processes of the 
exchanger, it is reasonable to assume that the intracellular Na+ and Ca2+, that mediate the 
allosteric regulation of the Na+/Ca2+ exchanger, can also interact with the blocking effect of 
the exchanger inhibitors.  
This idea is supported by experimental findings showing that inhibitory action of 
SEA0400 may be related to the kinetics of the Na+-dependent inactivation (I1 inactivation) of 
the Na+/Ca2+ exchanger (Iwamoto, 2004; Bouchard et al., 2004; Beauge and DiPolo, 2005). 
Although involvement of the Na+-dependent inactivation in the beat-to-beat regulation of the 
Na+/Ca2+ exchanger under normal physiological conditions is controversial, its existence can 
be clearly demonstrated in giant excised patch clamp experiments (Hilgemann, 1990). That 
is, when the concentration of Na+ is elevated rapidly in the cytoplasmic surface of the 
membrane, the outward Na+/Ca2+ exchanger current increases rapidly as well, but then it 
shows an inactivation which is dependent on the applied concentration of Na+. Investigating 
SEA0400 in this experimental configuration Bouchard et al. (Bouchard et al., 2004) 
concluded that SEA0400 accelerates the Na+-dependent inactivation of the outward 
exchanger current. Similarly, when analysing the effects of SEA0400 on mutant Na+/Ca2+ 
exchanger isoforms showing accelerated or eliminated I1 inactivation, Iwamoto et al. 
(Iwamoto et al. 2004) also concluded that the interaction of SEA0400 with the exchanger 
seems to stabilize the I1 inactivation state or accelerates the rate of entry into the I1 inactive 
state.  
However, as the Na+-dependent inactivation process was found to be dependent not 
only on Na+ but also on the regulatory Ca2+, i.e. increasing the concentration of the Ca2+ at 
the cytoplasmic surface decreased the rate and maximal extent of the Na+-dependent 
inactivation (Lee et al., 2004), it can be expected that the intracellular Ca2+ can also interact 
indirectly with the effect of SEA0400. Indeed, investigating the Na+/Ca2+ exchanger 
expressed in frog oocytes, Bouchard et al. (Bouchard et al., 2004) found an inverse Ca2+-
dependent inhibitory effect produced by SEA0400, as the percent inhibition of the total 
outward exchanger current was significantly decreased when the cytoplasmic free Ca2+ was 
elevated from 1 to 10 µM. This finding may be especially important regarding the action of 
SEA0400 on intact cardiac muscle, since the changes in the intracellular Ca2+ levels during 
the cardiac cycle is more pronounced than that of the intracellular Na+. 
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In connection with this issue we have shown in our work that the inverse Ca2+-
dependent inhibitory effect of SEA0400 can also be demonstrated in whole cell patch clamp 
experiment with ionic concentrations more closely resembling the physiological values than 
that of used by Bouchard et al. (note that they activated the reverse mode operation by 
applying 100 mM Na+ on the cytoplasmic surface and 8 mM Ca2+ on the extracellular side of 
the Na+/Ca2+ exchanger). At the same time our results indicate that the inverse Ca2+-
dependent inhibitory effect of SEA0400 occurs not only in expressed systems but also in 
adult mammalian cardiac myocytes. Furthermore, we demonstrated that this phenomenon 
applies not only to the reverse but also to the forward mode operation of the Na+/Ca2+ 
exchanger. 
The highest concentration of the intracellular free Ca2+ applied in our experiments was 
1 µM, which corresponds to the peak value of the intracellular Ca2+ transient measured by 
fluorescent Ca2+ indicators. At this Ca2+ level the observed inhibition of the Na+/Ca2+ 
exchanger by 1 µM SEA0400 was about 50 % of its maximal inhibitory effect, which is still 
a considerable value. However, during the Ca2+ cycle, the Na+/Ca2+ exchanger can sense 
significantly higher intracellular Ca2+ concentrations, especially at the subsarcolemmal space 
in the t-tubules, where the Ca2+ is released from the sarcoplasmic reticulum release channels. 
Furthermore, at the regions of the t-tubules, the functional density of the Na+/Ca2+ exchanger 
is about 3-4 fold higher (Frank et al., 1992; Despa et al., 2003) than in external sarcolemma. 
Therefore, in cardiac myocytes with intact Ca2+ handling the actual Ca2+-dependent decrease 
in the effect of SEA0400 can be more pronounced than it can be predicted from whole cell 
patch clamp experiments. The phenomenon of the inverse Ca2+-dependent inhibitory effect 
also implies that in intact cardiac myocytes the momentary inhibition of the Na+/Ca2+ 
exchanger produced by a given concentration of SEA0400 may change dynamically during 
the cardiac cycle, from its maximal value during diastole when the level of intracellular Ca2+ 
is low, to a pronouncedly blunted level when the intracellular free Ca2+ increases due to the 
Ca2+ induced Ca2+ release. However, as we measured the exchanger current in steady state 
conditions only, this possibility requires further support from experiments that allow dynamic 
measurement of this current.  
Practical consequences of this inverse Ca2+-dependent Na+/Ca2+ exchanger inhibition is 
unknown currently, but it may limit the effectivity of the actual inhibition produced by 
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SEA0400 in intact cardiac myocytes, which means that the inhibitory potency of the 
SEA0400 can be overestimated using steady state protocols in whole cell patch clamp 
experiments. From the point of view of possible therapeutic uses of the Na+/Ca2+ exchanger 
inhibitors, the inverse Ca2+-dependent exchanger inhibition can be an advantageous property, 
as it may limit the excessive blocking of the forward mode Na+/Ca2+ exchanger in intact 
cardiac myocytes, by which the dangerous Ca2+ overload can be avoided.  
 
6.3. Positive inotropic effect of SEA0400 in field stimulated rat cardiac myocytes 
 
When investigating the potential therapeutic uses of the Na+/Ca2+ exchanger inhibitors, 
it is important to explore their effect in the Ca2+ homeostasis, as changes occurring in the Ca2+ 
handling play a crucial role in the pathophysiology of most cardiac disorders. Therefore, we 
have investigated the effect of partial inhibition of the Na+/Ca2+ exchanger on the Ca2+ 
transient, which is a central parameter in the Ca2+ cycling in intact cardiac myocytes. 
Theoretically, consequences of a partial Na+/Ca2+ exchanger blockade depends on the relative 
degree of inhibition of the reverse and forward mode operation of Na+/Ca2+ exchanger, as 
well as on the relative contribution of the two modes of Na+/Ca2+ exchanger operation to the 
Ca2+ balance of the cell. For example, it has been shown that KB-R7943, a compound that 
predominantly blocks the reverse mode operation of the Na+/Ca2+ exchanger (see above) and 
thereby decreases the Ca2+ influx via Na+/Ca2+ exchanger, failed to affect the amplitude of 
either Ca2+ transients or contractions in rat cardiac myocytes (Satoh et al., 2000) suggesting 
that in this species the contribution of reverse mode Na+/Ca2+ exchanger to the total Ca2+ 
influx is negligible. However, both parameters were significantly decreased by KB-R7943 in 
guinea pig myocytes (Satoh et al., 2003), indicating that in this species the Ca2+ influx via the 
reverse mode Na+/Ca2+ exchanger plays a significant role in the initiation of the excitation 
contraction coupling. In contrast to KB-R7943, we and others have demonstrated that 
SEA0400 equally inhibits the forward and reverse mode operation of the Na+/Ca2+ exchanger 
(see above) in patch clamped myocytes (Tanaka et al., 2002; Birinyi et al., 2005). Based on 
these data, in rat cardiac myocytes accentuated consequences of the forward mode blockade 
of the Na+/Ca2+ exchanger may be anticipated with SEA0400 when comparing to results 
obtained with KB-R7943. Indeed, according to our results 0.3 µM SEA0400 significantly 
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increased the amplitude of Ca2+ transients and the cell shortening in field stimulated rat 
cardiac myocytes suggesting that significant intracellular accumulation of Ca2+ occurs as a 
consequence of the inhibition of Ca2+ efflux mode of the exchanger.  
In physiological conditions, the three main Ca2+ transport systems that compete for 
Ca2+ during the relaxation phase of the Ca2+ transient are the sarcoplasmic reticulum 
Ca2+-ATPase, the forward mode Na+/Ca2+ exchanger and the sarcolemmal Ca2+-ATPase. It 
can be assumed that if one of these mechanisms is inhibited, the decrease in the capacity of 
the Ca2+ removal systems results in slowing of the Ca2+ extrusion process, that is, the time 
constant of the relaxation rate can increase. However, an important finding in our 
experiments is that in intact cardiac myocytes the time constant of the Ca2+ transient 
relaxation does not change after the partial inhibition of the Na+/Ca2+ exchanger, suggesting 
that the role of the exchanger is negligible in governing the relaxation. This possibility is 
supported by the finding that the Na+/Ca2+ exchanger is found predominantly in the t-tubules 
of the sarcolemmal membrane (Frank et al., 1992; Despa et al., 2003), playing an important 
role in regulating the Ca2+ level near to the sarcoplasmic reticulum release channels during 
the Ca2+ induced Ca2+ release, i.e. during the upstroke of the Ca2+ transient, and having a 
significantly less role during the relaxation phase of the Ca2+ transient. Therefore, if the 
Na+/Ca2+ exchanger is inhibited, the amplitude of the Ca2+ transient can reach a higher value 
due to the diminished Ca2+ efflux from the vicinity of the transverse tubules, but the 
relaxation of the Ca2+ transient, although begins at an elevated Ca2+ level, can proceed with 
the same (or even elevated) rate constant, which is determined mainly by the sarcoplasmic 
reticulum Ca2+-ATPase. 
An important finding in our experiments on rat cardiac myocytes was to show that 
partial inhibition of Na+/Ca2+ exchanger may enhance contractility without significant 
elevation of the diastolic Ca2+ level. Although SEA0400 tended to increase the diastolic Ca2+ 
level, this tendency remained within the range of experimental variability. However, it must 
be kept in mind that when the Ca2+ extruding capacity of the cell is compromised due to 
partial inhibition of the Na+/Ca2+ exchanger, application of other agents influencing diastolic 
Ca2+ should be avoided in order to prevent the elevation of proarrhythmic risk, since an 
otherwise minor effect on diastolic Ca2+ can be potentiated by the reduced Ca2+ extruding 
capacity. The effect of Na+/Ca2+ exchanger inhibition on diastolic Ca2+ has particular 
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importance, because in heart failure the diastolic Ca2+ is elevated, and in this case application 
of drugs further increasing diastolic Ca2+ are contraindicated. From this point of view our 
results obtained with SEA0400 are in line with those obtained by Hobai et al. (Hobai et al., 
2004) using the exchange inhibitory peptide (XIP) applied intracellularly to study the effect 
of the reduced Na+/Ca2+ exchanger activity on Ca2+ handling in canine ventricular myocytes. 
They also observed increased amplitude of the Ca2+ transient without significant increase in 
diastolic Ca2+ concentration and argued that this may be due to the Ca2+-dependent 
stimulation of sarcoplasmic reticulum Ca2+ uptake, which is an important autoregulatory 
mechanism against cytoplasmic Ca2+ overload (Schouten, 1990). It is reasonable to assume 
that such a phenomenon may also occur under our experimental conditions, contributing to 
the increased sequestration of Ca2+ into the sarcoplasmic reticulum, which results in the 
observed positive inotropic action. 
 
6.4. SEA0400 fails to affect the intracellular Ca2+ transient in field stimulated dog 
cardiac myocytes 
 
Interestingly, in the same experimental setting a similar increase in the amplitude of 
Ca2+ transients in dog myocytes was not observed after administration of SEA0400 at 0.3 and 
even 1 µM concentration. The reason for this discrepancy between the results obtained in rat 
and dog myocytes is unknown. As SEA0400 proved to be a potent inhibitor of the Na+/Ca2+ 
exchanger in dog myocytes in whole cell patch clamp experiments, the possibility that 
SEA0400 did not inhibit the Na+/Ca2+ exchanger isoform or splice variant that is expressed in 
dog myocytes can be excluded. However, since the EC50 values of SEA0400 are very similar 
for inhibition of both the reverse and forward mode operation of the Na+/Ca2+ exchanger (see 
above), it can be assumed that SEA0400 equally inhibits both the Ca2+ influx and efflux 
mediated by the exchanger during the cardiac Ca2+ cycle, and thus its net effect does not 
cause any significant change in the Ca2+ transient. This explanation implies, however, that in 
dog cardiac myocytes the amount of Ca2+ transported by the reverse and forward mode 
exchanger is similar, which is not likely, because the majority of the Ca2+ influx is mediated 
by the L-type Ca2+ current. Thus this possibility can be held only if the blocked part of the 
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Ca2+ efflux via the forward mode exchanger is counterbalanced by other Ca2+ efflux systems, 
most likely by the sarcolemmal Ca2+ pump. 
The contribution of the different Ca2+ efflux systems to the extrusion of Ca2+ from the 
cytoplasm varies considerably between different species (Bers, 2001). In dog cardiac 
myocytes, however, this issue is less investigated. The only study available in the literature 
showed that the time required to achieve half relaxation during caffeine exposure (i.e. when 
the sarcoplasmic reticulum Ca2+ uptake is inhibited) showed a 4.4-fold increase when the 
Na+/Ca2+ exchanger was totally inactivated by application of Na+ and Ca2+ free solution, 
comparing to the value obtained when both the Na+/Ca2+ exchanger and the slow Ca2+ 
transport systems were active (Hobai and O'Rourke, 2000). In order to examine the 
possibility that in dog myocytes the sarcolemmal Ca2+ pump or other Ca2+ transport 
mechanisms can present a reserve system in the extrusion of Ca2+ from the cell we compared 
the relaxation rates of the caffeine induced Ca2+ transients in the presence and absence of 
fully active Na+/Ca2+ exchanger, i.e. before and after total inhibition of the exchanger by 10 
mM Ni2+. Our results showed that relaxation of the Ca2+ transient proceeded more slowly 
after total inhibition of the Ca2+ removal via the Na+/Ca2+ exchanger, resulting in a 4.8-fold 
increase in the half relaxation time. This value is in a good agreement with those obtained by 
Hobai et al. (see above). However, when investigating the Ca2+ extruding capacity of rat and 
rabbit myocytes in similar experimental setting, Bassani et al. (Bassani et al., 1994) found a 
8- and 10-fold increase in the relaxation time after inactivation of the Na+/Ca2+ exchanger, 
respectively. As these values relate inversely to the Ca2+ extruding capacity that remains after 
inactivation of the Na+/Ca2+ exchanger, these results indicate that in dog ventricular myocytes 
the Ca2+ removing systems other than the Na+/Ca2+ exchanger can display higher capacity 
than in other species. Therefore, although this type of experiment does not give any specific 
information about the dynamic interaction occurring between the different Ca2+ removal 
systems during the intact Ca2+ cycle, we can speculate that the lack of the effect of SEA0400 
on dog cardiac myocytes can be explained, at least in part, on the basis of a significant Ca2+ 
extruding capacity of the cell that can counterbalance the blocked part of the Na+/Ca2+ 
exchanger. 
To test further the hypothesis that the similar degree of inhibition exerted by SEA0400 
on both operating direction of the Na+/Ca2+ exchanger can account for the lack of apparent 
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effect on the Ca2+ handling in dog cardiac myocytes, we measured the Ca2+ transient in 
normal conditions and after decreasing the extracellular Na+ level from its normal value of 
144 mM to 70 mM. This intervention, in contrast to the effect of SEA0400, exerts an 
opposite effect on the two direction of the Na+/Ca2+ exchanger. That is, based on 
thermodynamic considerations the lower extracellular Na+ level decreases the forward mode 
operation while favours the reverse mode operation at any given intracellular concentrations 
of Na+ and Ca2+, which is due to a shift of the equilibrium potential of the Na+/Ca2+ 
exchanger to more positive values. Therefore, the Ca2+ efflux via the exchanger is inhibited 
partially as in the case of SEA0400, but, in contrast to SEA0400, the Ca2+ influx via the 
reverse mode exchanger increases, and theoretically the new equilibrium in the Ca2+ cycling 
develops with increased Ca2+ influx and elevated intracellular Ca2+ level. Indeed, we found a 
clear cut elevation in the amplitude of the Ca2+ transient after decreasing the extracellular Na+ 
level. However, this was only a moderate increase, which can suggest that if only a limited 
increase can be achieved in the Ca2+ transient when both the Ca2+ influx and Ca2+ efflux 
mode are modulated in the direction of Ca2+ accumulation, then it is possible that in case of 
SEA0400 the effects of decreased Ca2+ influx and efflux cancel each other, resulting in 
negligible effect on the Ca2+ transient. 
A different explanation for the lack of effect of SEA0400 on Ca2+ handling in dog 
cardiac myocytes involves the ionic dependence of the inhibitory effect of SEA0400. As we 
have discussed above the inhibition of the Na+/Ca2+ exchanger produced by SEA0400 
requires the presence of intracellular Na+, which allows the Na+-dependent inactivation of the 
Na+/Ca2+ exchanger to develop and SEA0400 accelerates this process. From this point of 
view, the intracellular Na+ has a permissive effect for the development of the inhibitory effect 
of SEA0400, and more pronounced consequences of the application of SEA0400 can be 
expected with higher intracellular Na+ levels. Congruently with this property, we have found 
a clear cut effect on the Ca2+ transient in rat, in which species the cytoplasmic Na+ 
concentration in the cardiac myocytes is considerably higher than in the myocytes from other 
species (Levi et al., 1994; Despa et al., 2002a). This possibility may have practical 
importance, as it is known that in heart failure the intracellular Na+ concentration is elevated 
(Despa et al., 2002b). Therefore, appearance of the positive inotropic action of the Na+/Ca2+ 
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exchanger inhibition can be expected in case of diseased heart compared to healthy heart. 
Further studies are required to prove these speculations.  
Whatever the background of the observed differing effect of SEA0400 in rat and dog 
myocytes, it is possible that this difference results from the unique mechanism of action of 
SEA0400, as inhibition of the Na+/Ca2+ exchanger by other means explicitly results in 
positive inotropic effect in dog myocytes as well (Hobai et al., 2004). Therefore, we can 
conclude that pharmacological inhibition of the Na+/Ca2+ exchanger can present a new 
mechanism in the positive inotropic therapy of heart failure.  
 
6.5. Further analysis of the changes in Ca2+ cycling caused by SEA0400 in rat 
ventricular myocytes 
 
Although SEA0400, applicated at a concentration of 0.3 µM was shown to block at 
least 50 % of Na+/Ca2+ exchanger activity (Birinyi et al., 2005), elevation of the intracellular 
Ca2+ transient observed in rat cardiac myocytes was not accompanied by signs of Ca2+ 
overload after the application of SEA0400 in the present study. It is likely, therefore, that 
according to the theory of autoregulation of Ca2+ handling in cardiac myocytes (Eisner et al., 
2000), a new steady state equilibrium in Ca2+ cycling has developed in the presence of 
SEA0400. In this case, Ca2+ influx had also to be decreased in order to achieve the new 
equilibrium between Ca2+ influx and efflux. To test this hypothesis we recorded the L-type 
Ca2+ current simultaneously with intracellular Ca2+ transients under perforated patch clamp 
conditions. The results showed that the amplitude of peak Ca2+ current actually decreased 
while its inactivation was accelerated after application of 0.3 µM SEA0400. We also 
demonstrated that SEA0400 at this concentration failed to affect directly the L-type Ca2+ 
current in whole cell patch clamp experiments, corresponding to previous findings obtained 
in guinea pig and dog cardiac myocytes (Tanaka et al., 2002; Birinyi et al., 2005). Therefore, 
one may conclude that the reduced Ca2+ current is an indirect consequence of the decreased 
Ca2+ extrusion, and is likely associated with the increased amplitude of the intracellular Ca2+ 
transient. The main mechanism underlying this phenomenon may be the Ca2+-dependent 
inactivation of the L-type Ca2+ channel (Findlay, 2004; Zahradnikova et al., 2004). This 
process is mediated through calmodulin (Anderson, 2001), and provides a beat to beat basis 
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for an automatic negative feedback mechanism playing a key role in the autoregulation of 
Ca2+ cycling (Eisner et al., 2000). As the cytosolic Ca2+ increases due to inhibition of the 
forward mode operation of Na+/Ca2+ exchanger, the increased Ca2+ load may result in 
increased sequestration of Ca2+ into the sarcoplasmic reticulum, and thus providing more 
Ca2+ to be released. Congruent with this explanation the diastolic Ca2+ level slightly increased 
after application of SEA0400. Although this change in diastolic Ca2+ was moderate and 
remained below the level of statistical significance, it might be sufficient to gradually 
increase the Ca2+ content of the sarcoplasmic reticulum during the experimental period 
leading to increased Ca2+ released into the subsarcolemmal space, which in turn might 
enhance the inactivation of L-type Ca2+ channels. However, if the reduced Ca2+ entry is able 
to initiate an increased Ca2+ transient, the new equilibrium may also involve changes in the 
gain of the Ca2+ induced Ca2+ release under such conditions. Further studies are required to 
elucidate the exact nature of this new equilibrium. 
It is worthy to mention that Tadros et al. (Tadros et al., 2002) investigating the effects 
of reduced Na+/Ca2+ exchanger function on the contractility and Ca2+ transient dynamics in 
rat ventricular cells came to different conclusions. Using adenovirus-mediated antisense 
oligonucleotid method to decrease the Na+/Ca2+ exchanger expression they found that the 
consequences of reduced Na+/Ca2+ exchanger expression on Ca2+ handling are largely 
dependent on extracellular Ca2+ concentration. More specifically, no significant change in the 
amplitude of Ca2+ transient at normal values (1.8 mM) of extracellular Ca2+ was observed in 
that study. This discrepancy between their and our results may be due to differences in 
experimental conditions (i.e. the methods used to reduce the activity of Na+/Ca2+ exchanger). 
The Na+/Ca2+ exchanger knockout induced by application of antisense oligonucleotids 
required 72 hours to develop, which allowed for adaptive changes in Ca2+ handling to occur, 
thus compensating for the compromised Na+/Ca2+ exchanger activity. Such adaptive changes 
are not likely to take place in our model, because of the acute application of the selective 
Na+/Ca2+ exchanger blocker. In addition, Tadros et al. found no change in L-type Ca2+ current 
after reduction of Na+/Ca2+ exchanger activity. This difference can also be ascribed to 
differences in the experimental techniques, since they measured L-type Ca2+ current using the 
conventional patch clamp method having intracellular Ca2+ buffered to non-physiologically 
low level. In contrast, the perforated patch clamp technique applied in our experiments, 
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allowed the changes in cytosolic Ca2+ to occur, and the observed reduction in the L-type Ca2+ 
current was possibly a consequence of the dynamic autoregulative adaptation of Ca2+ cycling 
after the inhibition of the Na+/Ca2+ exchanger.  
Therefore, we can conclude that the selective pharmacological inhibition of the 
Na+/Ca2+ exchanger as a research tool can be used in studying the Ca2+ homeostasis and its 
regulatory aspects in physiological experiments, and, at least in this type of experiments, its 
use may have advantages over the genetical methods. Moreover, regarding the possible 
therapeutic application of the pharmacological Na+/Ca2+ exchanger inhibition, as the 
defective excitation-contraction coupling in heart failure is characterized by a shift in the 
Ca2+ handling from the sarcoplasmic reticulum Ca2+ uptake to the sarcolemmal Ca2+ 
extrusion via the Na+/Ca2+ exchanger (Hobai and O’ Rourke, 2000 and 2004b), it can be 
anticipated that the pharmacological inhibition of the Na+/Ca2+ exchanger, which decreases 
the Ca2+ influx and Ca2+ efflux with a concomittant increase in the sarcoplasmic reticulum 
Ca2+ transport, may be a useful mechanism in the therapy of heart failure. 
 
7. Summary: conclusions and potential significance  
 
As involvement of the Na+/Ca2+ exchanger in pathophysiology of cardiac disorders 
have been suggested by recent studies, an emerging interest can be seen in using potent and 
selective Na+/Ca2+ exchanger inhibitors as research tools, in order to clarify the detailed role 
of the Na+/Ca2+ exchanger in physiological as well as pathological conditions and to explore 
the possible therapeutic value of the Na+/Ca2+ exchanger inhibitors. Our first aim in this work 
was to compare the inhibitory properties of SEA0400 and KB-R7943, the two most 
commonly used Na+/Ca2+ exchanger inhibitors. We conclude that SEA0400, at sub-
micromolar concentrations, can be effectively used in the Na+/Ca2+ exchanger research, as it 
blocks the exchanger current selectively and with higher potency than KB-R7943. 
We have also investigated the possible interaction between the intracellular Ca2+ level 
and the inhibitory effect of SEA0400, and our results demonstrate that the hypothesized 
reverse Ca2+-dependent inhibition of the Na+/Ca2+ exchanger can indeed occur in adult 
cardiac myocytes, with ionic concentrations being in the physiological range. Reverse Ca2+-
dependent inhibition by SEA0400 of the Na+/Ca2+ exchanger can have practical importance 
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from therapeutical point of view, as it may provide an inherent limiting mechanism against 
the excessive blocking of the exchanger, thereby avoiding dangerous elevation of the 
intracellular Ca2+ level and the consequent increase in the proarrhythmic risk, which is a 
serious problem in the conventional therapy of heart failure.  
By application of SEA0400 we are first to compare the consequences of selective 
pharmacological inhibition of the cardiac Na+/Ca2+ exchanger in intact rat and dog cardiac 
myocytes, showing a significant positive inotropic effect in rat myocytes. These species differ 
from each other substantially regarding the characteristics of their action potential waveform, 
intracellular Na+ concentration and Ca2+ homeostasis, and it is likely that the differing effect 
of SEA0400 can be attributed mainly to these differences, as the mechanism of action of 
SEA0400 may have strong dependence on the intracellular ionic milieu. This phenomenon 
may possess advantages in the therapy of heart failure, as augmentation of the exchanger 
inhibitory effect can be expected in diseased heart with elevated intracellular Na+ 
concentration. A further possible advantage of the Na+/Ca2+ exchanger inhibition over the 
conventional positive inotropic therapy is the concomitant reduction of the depolarizing 
inward current carried by the forward mode exchanger, which reduces the proarrhythmic risk 
associated with the elevated Ca2+ level during the therapy of heart failure. 
In rat cardiac myocytes, we have also demonstrated the autoregulative nature of the 
Ca2+ homeostasis, indicating that SEA0400, as a selective pharmacological tool, may be 
useful in studying the cellular Ca2+ homeostasis. The observed change in the Ca2+ fluxes 
further supports the possibility that inhibition of the Na+/Ca2+ exchanger can exert a 
beneficial effect on the defective Ca2+ homeostasis in heart failure, as it can shift the Ca2+ 
flux balance toward an increased Ca2+  sequestration into the sarcoplasmic reticulum, 
resulting in elevated Ca2+ transients and cell contraction.  
Although the potential application of the Na+/Ca2+ exchanger inhibitors in human 
therapy requires further detailed studies, our work suggest that such a mechanism of action, 
with its advantageous dependence on the intracellular ionic environment of the diseased 
heart, may possess therapeutic importance in the future. 
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